This Capex was higher than the mkt wanted or expected. The company has stated many times since Dec2012 that it was optimising the DFS. The last presso in June14 says "simplifying plant and infrastructure design.. Optimising Capex.."
I would expect a lower Capex number when they eventually get it out. Hard to say where the savings will come from or by how much, but any improvement would go straight onto NPV.
On the plus side, the tighter Zn market is jamming the C1 number down, currently +14% compared to DFS assumption.
- Forums
- ASX - By Stock
- DVP
- EBIT $550m cash costs $1.57/lb Cu
EBIT $550m cash costs $1.57/lb Cu, page-8
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DVP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.19 |
Change
-0.060(2.67%) |
Mkt cap ! $594.4M |
Open | High | Low | Value | Volume |
$2.23 | $2.29 | $2.17 | $1.364M | 613.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3846 | $2.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.21 | 4808 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3846 | 2.170 |
2 | 5846 | 2.160 |
2 | 7665 | 2.150 |
1 | 3846 | 2.140 |
2 | 13846 | 2.130 |
Price($) | Vol. | No. |
---|---|---|
2.210 | 4808 | 1 |
2.220 | 4808 | 1 |
2.230 | 4808 | 1 |
2.240 | 4808 | 1 |
2.250 | 1500 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
DVP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online